UK markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
69.00-0.56 (-0.81%)
At close: 4:00PM EST
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2020
30/09/2019
30/09/2018
30/09/2017
Total revenue
163,592
87,992
168,796
16,142
31,408
Operating expenses
Research development
86,850
128,875
81,049
52,969
31,690
Selling general and administrative
31,206
52,276
26,556
19,110
32,023
Total operating expenses
118,201
181,151
107,605
72,079
68,404
Operating income or loss
45,392
-93,159
61,191
-55,936
-36,996
Total other income/expenses net
-
-582.524
-
439.634
2,203
Income before tax
53,437
-84,551
68,148
-54,448
-34,378
Income tax expense
173.553
2.4
173.553
2.4
2.4
Income from continuing operations
53,264
-84,553
67,975
-54,450
-34,380
Net income
53,264
-84,553
67,975
-54,450
-34,380
Net income available to common shareholders
53,264
-84,553
67,975
-54,450
-34,380
Basic EPS
-
-0.84
0.72
-0.65
-0.47
Diluted EPS
-
-0.84
0.69
-0.65
-0.47
Basic average shares
-
100,722
93,859
83,638
73,899
Diluted average shares
-
100,722
98,608
83,638
73,899
EBITDA
-
-87,217
65,630
-51,237
-32,305